Scott Karlan

857 total citations
16 papers, 376 citations indexed

About

Scott Karlan is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Scott Karlan has authored 16 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Scott Karlan's work include Breast Cancer Treatment Studies (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Salivary Gland Disorders and Functions (2 papers). Scott Karlan is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Salivary Gland Disorders and Functions (2 papers). Scott Karlan collaborates with scholars based in United States and Norway. Scott Karlan's co-authors include Beth Y. Karlan, Jenny Gross, David T. Wong, David Elashoff, David Chia, Xinmin Yan, Hua Xiao, David Akin, Hui Zhou and Lei Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Scott Karlan

15 papers receiving 365 citations

Peers

Scott Karlan

PHYSI

SURGE

PERIO

Daniele Xavier Assad Brazil

Roger Wei Canada

Denise de Abreu Pereira Brazil

Qiwei Yao China

Pavithra Shyamsunder Singapore

Xiaochang Gong China

Noemy Starita Italy

Megha Bhardwaj Germany

Jullet Han United States

Daniele Xavier Assad Brazil

Scott Karlan

132 ×0.9

81 ×0.7

PHYSI

48 ×0.5

32 ×0.5

SURGE

34 ×0.5

PERIO

Citations per year, relative to Scott Karlan Scott Karlan (= 1×) peers Daniele Xavier Assad

Countries citing papers authored by Scott Karlan

Since Specialization

Citations

This map shows the geographic impact of Scott Karlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Karlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Karlan more than expected).

Fields of papers citing papers by Scott Karlan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Karlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Karlan. The network helps show where Scott Karlan may publish in the future.

Co-authorship network of co-authors of Scott Karlan

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Karlan. A scholar is included among the top collaborators of Scott Karlan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Karlan. Scott Karlan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Ho, Alice Y., Stephen L. Shiao, Jonathan Chen, et al.. (2024). PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer. Journal of Clinical Oncology. 42(36). 4282–4293. 6 indexed citations

Lee, Oukseub, Latifa A. Bazzi, Yanfei Xu, et al.. (2024). A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects. Biomedicine & Pharmacotherapy. 171. 116105–116105. 2 indexed citations

Chung, Alice, Catherine Dang, Scott Karlan, et al.. (2024). A Prospective Study of Sentinel Node Biopsy Omission in Women Age ≥ 65 Years with ER+ Breast Cancer. Annals of Surgical Oncology. 31(5). 3160–3167. 5 indexed citations

McArthur, Heather L., Stephen L. Shiao, Scott Karlan, et al.. (2021). Abstract PS12-09: Pre-operative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC). Cancer Research. 81(4_Supplement). PS12–9. 5 indexed citations

McArthur, Heather L., Stephen L. Shiao, Scott Karlan, et al.. (2020). Abstract P3-09-09: Pre-operative pembrolizumab (pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC). Cancer Research. 80(4_Supplement). P3–9. 3 indexed citations

Lee, Oukseub, Melissa Pilewskie, Scott Karlan, et al.. (2020). Local Transdermal Delivery of Telapristone Acetate Through Breast Skin, Compared With Oral Treatment: A Randomized Double‐Blind, Placebo‐Controlled Phase II Trial. Clinical Pharmacology & Therapeutics. 109(3). 728–738. 17 indexed citations

McArthur, Heather L., Reva Basho, Stephen L. Shiao, et al.. (2018). Preoperative pembrolizumab (Pembro) with radiation therapy (RT) in patients with operable triple-negative breast cancer (TNBC). Annals of Oncology. 29. viii86–viii86. 2 indexed citations

Schummer, Michèl, Ann Green, J. David Beatty, et al.. (2010). Comparison of Breast Cancer to Healthy Control Tissue Discovers Novel Markers with Potential for Prognosis and Early Detection. PLoS ONE. 5(2). e9122–e9122. 20 indexed citations

Schummer, Michèl, Ann Green, Beth Y. Karlan, et al.. (2010). Correction: Comparison of Breast Cancer to Healthy Control Tissue Discovers Novel Markers with Potential for Prognosis and Early Detection. PLoS ONE. 5(4). 5 indexed citations

10.

Zhang, Lei, Hua Xiao, Scott Karlan, et al.. (2010). Discovery and Preclinical Validation of Salivary Transcriptomic and Proteomic Biomarkers for the Non-Invasive Detection of Breast Cancer. PLoS ONE. 5(12). e15573–e15573. 217 indexed citations

11.

Zhang, Lei, Hua Xiao, Scott Karlan, et al.. (2010). Abstract 2726: Salivary biomarkers for breast cancer detection. Cancer Research. 70(8_Supplement). 2726–2726.

12.

Dang, Catherine, Karen Zaghiyan, Scott Karlan, & Edward H Phillips. (2009). Increased Use of MRI for Breast Cancer Surveillance and Staging is Not Associated with Increased Rate of Mastectomy. The American Surgeon. 75(10). 937–940. 12 indexed citations

13.

Chung, Alice, et al.. (2006). In vivo cytometry: A spectrum of possibilities. Cytometry Part A. 69A(3). 142–146. 34 indexed citations

14.

Chung, Alice, Mark Gaon, Ji-Hoon Jeong, et al.. (2006). Spectral imaging detects breast cancer in fresh unstained specimens. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 6088. 608806–608806. 3 indexed citations

15.

Tang, Jun, Paul F. White, Ronald H. Wender, et al.. (2001). Fast-Track Office-Based Anesthesia: A Comparison of Propofol Versus Desflurane with Antiemetic Prophylaxis In Spontaneously Breathing Patients. Anesthesia & Analgesia. 92(1). 95–99. 42 indexed citations

16.

Karlan, Scott. (1987). Stoma therapy: An atlas and guide for intestinal stomas. Gastroenterology. 92(3). 833–833. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact